文献速递间质性肺疾病呼吸危重症与机械通气

肺移植物抗宿主病与慢性肺移植物功能障碍:同一枚硬币的两面?

Pulmonary graft-versus-host disease and chronic lung allograft dysfunction: two sides of the same coin?
PubMed 文献 · Lancet Respir Med · 2022-05-02

本文综述比较异基因造血干细胞移植后的肺慢性移植物抗宿主病(cGVHD)与肺移植后的慢性肺移植物功能障碍(CLAD)。两者在免疫病理上相似,均导致移植相关肺纤维化和结构重塑,进而引起呼吸功能障碍。文章强调准确临床识别和适当管理对及时诊断、优化防治策略及改善长期预后至关重要。

要点

  • 肺cGVHD与CLAD在免疫病理上相似,均导致肺纤维化和结构重塑。
  • 肺cGVHD预后很差,CLAD是肺移植长期生存的主要障碍。
  • 呼吸科医生应准确识别两者,以优化预防和治疗策略。

核心结论

  • 肺cGVHD与CLAD虽发生于不同移植类型,但具有相似的免疫病理和纤维化重塑过程。

研究设计与样本

  • 本文为叙述性综述,面向呼吸照护从业者提供两种疾病的最新视角。

主要发现

  • 肺cGVHD与CLAD均以相似的免疫病理为特征,导致移植相关肺纤维化和结构重塑。
  • 肺cGVHD预后很差,CLAD阻碍肺移植长期生存。

临床怎么用

  • 呼吸科医生应准确临床识别肺cGVHD和CLAD,以促进及时诊断并优化防治策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Allogeneic haematopoietic stem-cell transplantation (HSCT) and lung transplantation are both established life-saving treatment options for carefully selected patients with various haematological disorders or end-stage lung diseases, respectively. However, long-term survival after allogeneic HSCT is severely limited by chronic graft-versus-host disease (cGVHD)-of which pulmonary cGVHD in particular has a very poor prognosis-and long-term survival after lung transplantation is hampered by chronic lung allograft dysfunction (CLAD). Both pulmonary cGVHD and CLAD are characterised by similar underlying immunopathology, which results in transplant-related pulmonary fibrosis and structural lung remodelling, leading to respiratory dysfunction. Accurate clinical identification and appropriate management is of utmost importance to allow for timely diagnosis, to further optimise current preventive and treatment strategies of pulmonary cGVHD and CLAD, and to ameliorate quality of life and long-term outcomes after allogeneic HSCT and lung transplantation. In this Review, we provide a unique state-of-the-art perspective of both entities for respiratory care practitioners.

来源:Lancet Respir Med,查看原文。版权归原作者所有。

引用

  1. Bos S, Beeckmans H, Vanstapel A, et al. Pulmonary graft-versus-host disease and chronic lung allograft dysfunction: two sides of the same coin? Lancet Respir Med. 2022. PMID: 35512715. doi:10.1016/S2213-2600(22)00001-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。